Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 2
1987 3
1988 4
1989 2
1990 4
1991 5
1992 1
1993 4
1994 5
1995 5
1996 2
1997 2
1998 3
1999 3
2000 6
2001 4
2003 2
2004 2
2006 2
2007 1
2008 6
2009 2
2010 3
2011 5
2012 3
2014 2
2015 1
2017 2
2018 2
2019 2
2020 1
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

92 results
Results by year
Filters applied: . Clear all
Page 1
CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
Fukasawa K, Kadota T, Horie T, Tokumura K, Terada R, Kitaguchi Y, Park G, Ochiai S, Iwahashi S, Okayama Y, Hiraiwa M, Yamada T, Iezaki T, Kaneda K, Yamamoto M, Kitao T, Shirahase H, Hazawa M, Wong RW, Todo T, Hirao A, Hinoi E. Fukasawa K, et al. Among authors: shirahase h. Oncogene. 2021 Apr;40(15):2803-2815. doi: 10.1038/s41388-021-01745-1. Epub 2021 Mar 16. Oncogene. 2021. PMID: 33727660
Synthesis and Evaluation of a Novel Series of 2,7-Substituted-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Selective Peroxisome Proliferator-Activated Receptor γ Partial Agonists.
Morishita K, Ito Y, Otake K, Takahashi K, Yamamoto M, Kitao T, Ozawa SI, Hirono S, Shirahase H. Morishita K, et al. Among authors: shirahase h. Chem Pharm Bull (Tokyo). 2021;69(4):333-351. doi: 10.1248/cpb.c20-00841. Chem Pharm Bull (Tokyo). 2021. PMID: 33790079 Free article.
92 results